Prentice R, Flanagan E, Wright EK, Gibson PR, et al. Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero. Clin Gastroenterol Hepatol 2024 Mar 14:S1542-3565(24)00252.
PMID: 38492905